David Linetsky Sells 2,059 Shares of Phreesia (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) insider David Linetsky sold 2,059 shares of the firm’s stock in a transaction that occurred on Friday, October 17th. The shares were sold at an average price of $22.36, for a total value of $46,039.24. Following the completion of the sale, the insider owned 171,829 shares in the company, valued at approximately $3,842,096.44. This represents a 1.18% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

David Linetsky also recently made the following trade(s):

• On Thursday, September 18th, David Linetsky sold 93 shares of Phreesia stock. The shares were sold at an average price of $23.94, for a total transaction of $2,226.42.
• On Wednesday, September 17th, David Linetsky sold 1,064 shares of Phreesia stock. The shares were sold at an average price of $23.50, for a total transaction of $25,004.00.
• On Tuesday, September 16th, David Linetsky sold 2,165 shares of Phreesia stock. The shares were sold at an average price of $23.28, for a total transaction of $50,401.20.
• On Friday, August 22nd, David Linetsky sold 17,445 shares of Phreesia stock. The stock was sold at an average price of $29.73, for a total transaction of $518,639.85.
• On Monday, August 18th, David Linetsky sold 78 shares of Phreesia stock. The stock was sold at an average price of $29.16, for a total transaction of $2,274.48.

Phreesia Price Performance

NYSE PHR opened at $23.42 on Thursday. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $32.76. The firm has a market capitalization of $1.40 billion, a PE ratio of -55.76 and a beta of 0.68. The company’s 50 day simple moving average is $25.82 and its 200 day simple moving average is $25.95. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.12 and a quick ratio of 2.12.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.08. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The company had revenue of $117.26 million for the quarter, compared to analysts’ expectations of $116.39 million. During the same period last year, the firm earned ($0.03) EPS. The firm’s revenue for the quarter was up 14.9% on a year-over-year basis. Phreesia has set its FY 2026 guidance at EPS. As a group, equities research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Institutional Trading of Phreesia

Large investors have recently added to or reduced their stakes in the company. Asset Management One Co. Ltd. purchased a new stake in shares of Phreesia in the third quarter valued at $45,000. VIRGINIA RETIREMENT SYSTEMS ET Al raised its position in Phreesia by 24.4% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 23,480 shares of the company’s stock valued at $552,000 after buying an additional 4,600 shares during the period. Diversified Trust Co lifted its stake in Phreesia by 1.7% in the 3rd quarter. Diversified Trust Co now owns 45,822 shares of the company’s stock worth $1,078,000 after acquiring an additional 780 shares in the last quarter. BankPlus Trust Department boosted its position in Phreesia by 883.4% during the 3rd quarter. BankPlus Trust Department now owns 8,880 shares of the company’s stock worth $209,000 after acquiring an additional 7,977 shares during the period. Finally, Capricorn Fund Managers Ltd purchased a new position in Phreesia during the 3rd quarter valued at about $11,395,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

PHR has been the subject of several research reports. Citigroup restated an “outperform” rating on shares of Phreesia in a research report on Monday, September 8th. Mizuho started coverage on shares of Phreesia in a research note on Wednesday, August 27th. They set an “outperform” rating and a $36.00 target price for the company. Canaccord Genuity Group lifted their price target on shares of Phreesia from $34.00 to $38.00 and gave the stock a “buy” rating in a research report on Friday, September 5th. KeyCorp dropped their price target on Phreesia from $35.00 to $32.00 and set an “overweight” rating on the stock in a report on Wednesday, October 8th. Finally, JMP Securities raised their price objective on Phreesia from $30.00 to $34.00 and gave the stock a “market outperform” rating in a research note on Monday, September 8th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $33.85.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.